Leo Pavliv - 31 May 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Reporting relationship: SVP and Chief Development Off.
Issuer ticker: CPIX
Reported as of: 31 May 2022
Net transaction value: -$70,015
SEC form: 4
Accepted by SEC: 01 Jul 2022, 15:13:03 UTC
Prior SEC filing: 29 Apr 2022
Source filing: View source filing
Reporting owner signature: Leo Pavliv by /s/ John Hamm as attorney-in-fact

Key filing fact

Leo Pavliv filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 01 Jul 2022.

Key facts

This page summarizes Leo Pavliv's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 01 Jul 2022, 15:13.

Change

Previous filing in this sequence was filed on 29 Apr 2022.
Current net transaction value: -$70,015.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CPIX transaction

Common Stock

Other

Transaction value: $70,015
Shares: -33,500
Change %: -21%
Price: $2.09
Shares after: 129,618
Date: 31 May 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CPIX transaction Derivative

Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -5,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Mar 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $3.22
Footnotes: F1

CPIX transaction Derivative

Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -5,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 16 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $2.59
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Leo Pavliv is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022. All unvested equity awards forfeited upon retirement.